Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nanobiotix (NBTX) Treasury Shares (2019 - 2025)

Nanobiotix has reported Treasury Shares over the past 7 years, most recently at $265401.9 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 8.93% year-over-year to $265401.9; the TTM value through Dec 2025 reached $265401.9, up 8.93%, while the annual FY2025 figure was $265401.9, 8.93% up from the prior year.
  • Treasury Shares for Q4 2025 was $265401.9 at Nanobiotix, up from -$258086.8 in the prior quarter.
  • Over five years, Treasury Shares peaked at $265401.9 in Q4 2025 and troughed at -$258086.8 in Q2 2025.
  • A 5-year average of -$4417.0 and a median of -$7224.1 in 2021 define the central range for Treasury Shares.
  • On a YoY basis, Treasury Shares climbed as much as 8.93% in 2025 and fell as far as 5.11% in 2025.
  • Year by year, Treasury Shares stood at $231082.1 in 2021, then rose by 0.66% to $232616.4 in 2022, then grew by 5.46% to $245314.3 in 2023, then decreased by 0.68% to $243639.8 in 2024, then increased by 8.93% to $265401.9 in 2025.
  • Business Quant data shows Treasury Shares for NBTX at $265401.9 in Q4 2025, -$258086.8 in Q2 2025, and $243639.8 in Q4 2024.